Skip to main content

Advertisement

SpringerLink
Log in

Nutritional interventions in elderly gastrointestinal cancer patients: the evidence from randomized controlled trials

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Literature concerning nutritional interventions in elderly patients with gastrointestinal cancer, with special reference to randomized clinical trials, has been critically reviewed. This segment of oncologic population was found to be penalized by a high prevalence of malnutrition and sarcopenia which translated in an increased rate of toxicity from chemotherapy, poor compliance with oncologic treatments, and, finally, with a poor prognosis. Attempts to reverse this condition included a potentiation of nutrients intake which should sequentially proceed through the use of dietary counseling and administration of standard or ω-3 fatty acid–enriched oral supplements to finally come to enteral or parenteral nutrition. Randomized clinical trials investigating the effects of simple dietary advice and use of standard oral supplements were disappointing as regards long-term compliance and results. Nutritional and clinical benefits were reported with the use of ω-3 fatty acid–enriched oral supplements and especially with long-term supplemental parenteral nutrition. Despite the general recommendation of the scientific community that emphasizes the use of the enteral route, whenever possible, for delivering the nutritional support, it appears from the literature that more consistent benefits can be achieved, especially in the long-term nutritional support, when an insufficient oral nutrition is partnered with intravenous nutrition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yancik R (2005) Population aging and cancer: a cross-national concern. Cancer J 11(6):437–441

    Article  PubMed  Google Scholar 

  2. Yancik R, Ries LA (1994) Cancer in older persons. Magnitude of the problem - how do we apply what we know? Cancer 74:1995–2003

    Article  CAS  PubMed  Google Scholar 

  3. Ferlay JSI, Ervik M, Dikshit R et al (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon

    Google Scholar 

  4. Bozzetti F (2003) Nutritional issues in the care of the elderly patient. Crit Rev Oncol Hematol 48(2):113–121

    Article  PubMed  Google Scholar 

  5. Lacau S, Guily J, Bouvard É et al (2017) NutriCancer: a French observational multicentre cross-sectional study of malnutrition in elderly patients with cancer. J Geriatr Oncol 9:74–80

    Article  Google Scholar 

  6. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group (1991) Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325(8):525–532

    Article  Google Scholar 

  7. Guigoz Y, Vellas J, Garry P (1994) Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts Res Gerontol 4(supp. 2):15–59

    Google Scholar 

  8. Barret M, Malka D, Aparicio T, Dalban C, Locher C, Sabate JM, Louafi S, Mansourbakht T, Bonnetain F, Attar A, Taieb J (2011) Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 81(5–6):395–402

    Article  CAS  PubMed  Google Scholar 

  9. Sánchez-Lara K, Ugalde-Morales E, Motola-Kuba D, Green D (2013) Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy. Br J Nutr 109(5):894–897

    Article  CAS  PubMed  Google Scholar 

  10. Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, Latko E, Taieb J (2014) Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer 66(4):583–589

    Article  CAS  PubMed  Google Scholar 

  11. Vagnildhaug OM, Blum D, Wilcock A, European Palliative Care Cancer Symptom study group et al (2017) The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis. J Cachexia Sarcopenia Muscle 8(5):789–797

    Article  PubMed  PubMed Central  Google Scholar 

  12. Fonck M, Brunet R, Becouarn Y et al (2011) Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II study. Clin Res Hepatol Gastroenterol 35(12):823–830

    Article  CAS  PubMed  Google Scholar 

  13. Aaldriks AA, van der Geest LG, Giltay EJ et al (2013) Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol 4(3):218–262

    Article  PubMed  Google Scholar 

  14. Paillaud E, Liuu E, Laurent M et al (2014) ELCAPA study group. Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumour site and metastatic status. Clin Nutr 33(2):330–335

    Article  CAS  PubMed  Google Scholar 

  15. Bosaeus I, Daneryd P, Lundholm K (2002) Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 132(11 Suppl):3465S–3466S

    Article  CAS  PubMed  Google Scholar 

  16. Fearon KC, Voss AC, Hustead DS (2006) Cancer Cachexia study group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83(6):1345–1350

    Article  CAS  PubMed  Google Scholar 

  17. Cederholm T, Barazzoni R, Austin P et al (2017) ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 36(1):49–64

    Article  CAS  PubMed  Google Scholar 

  18. Aviles A, Yanez J, Garcia EL et al (1995) Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 26:31–34

    CAS  PubMed  Google Scholar 

  19. Di Fiore F, Lecleire S, Pop D et al (2007) Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 102:2557–2563

    Article  CAS  PubMed  Google Scholar 

  20. Mitry E, Douillard JY, Van Cutsem E et al (2004) Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. Ann Oncol 15:1013–1017

    Article  CAS  PubMed  Google Scholar 

  21. Ross PJ, Ashley S, Priest K et al (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90:1905–1911

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Andreyev HJN, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34(4):503–509

    Article  CAS  PubMed  Google Scholar 

  23. Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, Hansen OP (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11:2043–2049

    Article  CAS  PubMed  Google Scholar 

  24. Van Eys J (1982) Effect of nutritional status on response to therapy. Cancer Res 42(2 Suppl):747–753

    Google Scholar 

  25. Tubiana M, Attié E, Flamant R et al (1971) Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res 31:1801–1810

    CAS  PubMed  Google Scholar 

  26. Swenerton KD, Legha SS, Smith T et al (1979) Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39(5):1552–1562

    CAS  PubMed  Google Scholar 

  27. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629–635

    Article  PubMed  Google Scholar 

  28. Martin L, Birdsell L, Macdonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547

    Article  PubMed  Google Scholar 

  29. Tan BH, Brammer K, Randhawa N et al (2015) Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 41(3):333–338

    Article  CAS  PubMed  Google Scholar 

  30. Anandavadivelan P, Brismar TB, Nilsson M et al (2016) Sarcopenic obesity: a probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr 35(3):724–730

    Article  CAS  PubMed  Google Scholar 

  31. Palmela C, Velho S, Agostinho L et al (2017) Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric Cancer. J Gastric Cancer 17(1):74–87

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lecleire S, Di Fiore F, Antonietti M et al (2006) Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc 64(4):479–484

    Article  PubMed  Google Scholar 

  33. Barao K, Abe Vicente Cavagnari M, Silva Fucuta P, Manoukian Forones N (2017) Association between nutrition status and survival in elderly patients with colorectal cancer. Nutr Clin Pract 32(5):658–663

    Article  PubMed  Google Scholar 

  34. Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Negative impact of skeletal muscle loss after systemic chemotherapy in patients with Unresectable colorectal Cancer. PLoS One 10(6):e0129742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63(1):131–140

    Article  CAS  PubMed  Google Scholar 

  36. Iritani S, Imai K, Takai K et al (2015) Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 50(3):323–332

    Article  CAS  PubMed  Google Scholar 

  37. Kamachi S, Mizuta T, Otsuka T et al (2016) Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatol Res 46(2):201–208

    Article  CAS  PubMed  Google Scholar 

  38. van Vledder MG, Levolger S, Ayez N et al (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99(4):550–557

    Article  PubMed  Google Scholar 

  39. Arends J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48

    Article  PubMed  Google Scholar 

  40. Baldwin C, Weekes CE (2012) Dietary counselling with or without oral nutritional supplements in the management of malnourished patients: a systematic review and meta-analysis of randomised controlled trials. J Hum Nutr Diet 25(5):411–426

    Article  CAS  PubMed  Google Scholar 

  41. Baldwin C, Spiro A, Ahern R, Emery PW (2012) Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 104(5):371–385

    Article  PubMed  Google Scholar 

  42. Persson CR, Johansson BB, Sjöden PO, Glimelius BL (2002) A randomized study of nutritional support in patients with colorectal and gastric cancer. Nutr Cancer 42(1):48–58

    Article  PubMed  Google Scholar 

  43. Baldwin C, Spiro A, McGough C et al (2011) Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet 24(5):431–440

    Article  CAS  PubMed  Google Scholar 

  44. Bourdel-Marchasson I, Blanc-Bisson C, Doussau A et al (2014) Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One 9(9):e108687

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Kuroda H, Ushio A, Miyamoto Y et al (2010) Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial. J Gastroenterol Hepatol 25(9):1550–1555

    Article  CAS  PubMed  Google Scholar 

  46. Fearon KC, Von Meyenfeldt MF, Moses AG et al (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10):1479–1486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Moses AW, Slater C, Preston T et al (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90(5):996–1002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Bauer J, Capra S, Battistutta D, Cancer Cachexia study group et al (2005) Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr 24(6):998–1004

    Article  PubMed  Google Scholar 

  49. Shirai Y, Okugawa Y, Hishida A et al (2017) Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia. Sci Rep 7(1):4826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Lundholm K, Daneryd P, Bosaeus I et al (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100(9):1967–1977

    Article  CAS  PubMed  Google Scholar 

  51. Lundholm K, Körner U, Gunnebo L et al (2007) Insulin treatment. Cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13(9):2699–2706

    Article  CAS  PubMed  Google Scholar 

  52. Obling SR, Wilson VB, Pfeiffer P, Kjeldsen J (2017) Home parenteral nutrition increases fat-free mass in incurable gastrointestinal cancer patients. Results of a randomised clinical trial. Clin Nutr. https://doi.org/10.1016/j.clnu.2017.12.011

  53. Bozzetti F (2017) Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol 28(9):2107–2118

    Article  CAS  PubMed  Google Scholar 

  54. Solheim TS, Laird BJ (2012) Evidence base for multimodal therapy in cachexia. Curr Opin Support Palliat Care 6(4):424–431

    Article  PubMed  Google Scholar 

  55. Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, Pettersen CH, Fallon M, Fayers P, Fearon K, Kaasa S (2017) A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle 8(5):778–788

    Article  PubMed  PubMed Central  Google Scholar 

  56. Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742

    Article  CAS  PubMed  Google Scholar 

  57. Grosvenor M, Bulcavage L, Chlebowski RT (1989) Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 63:330–334

    Article  CAS  PubMed  Google Scholar 

  58. Cotogni P, De Carli L, Passera R et al (2017) Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med 6(7):1799–1806

    Article  PubMed  PubMed Central  Google Scholar 

  59. Culine S, Chambrier C, Tadmouri A et al (2014) Home parenteral nutrition improves quality of life and nutritional status in patients with cancer: a French observational multicentre study. Support Care Cancer 22(7):1867–1874

    Article  CAS  PubMed  Google Scholar 

  60. Vashi PG, Dahlk S, Popiel B et al (2014) A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer 14:593. https://doi.org/10.1186/1471-2407-14-593

    Article  PubMed  PubMed Central  Google Scholar 

  61. Lim STK, Choa RG, Lan KH, Ong GB (1981) Total parenteral nutrition versus gastrostomy in the preoperative preparation of patients with carcinoma of the oesophagus. Br J Surg 68:69–72

    Article  CAS  PubMed  Google Scholar 

  62. Pearlstone DB, Lee JI, Alexander RH, Chang TH, Brennan MF, Burt M (1995) Effect of enteral and parenteral nutrition on amino acid levels in cancer patients. JPEN J Parenter Enteral Nutr 19:204–208

    Article  CAS  PubMed  Google Scholar 

  63. Burt ME, Stein TP, Brennan MF (1983) A controlled, randomized trial evaluating the effects of enteral and parenteral nutrition on protein metabolism in cancer-bearing man. J Surg Res 34:303–314

    Article  CAS  PubMed  Google Scholar 

  64. Nixon DW, Lawson DH, Kutner M, Ansley J, Schwarz M, Heymsfield S, Chawla R, Cartwright TH, Rudman D (1981) Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res 41:2038–2045

    CAS  PubMed  Google Scholar 

  65. Dresler CM, Jeevanandam M, Brennan MF (1987) Metabolic efficacy of enteral feeding in malnourished cancer and noncancer patients. Metabolism 36:82–88

    Article  CAS  PubMed  Google Scholar 

  66. Orrevall Y, Tishelman C, Permert J (2005) Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 24(6):961–970

    Article  PubMed  Google Scholar 

  67. Orrevall Y, Tishelman C, Permert J, Lundström S (2013) A national observational study of the prevalence and use of enteral tube feeding, parenteral nutrition and intravenous glucose in cancer patients enrolled in specialized palliative care. Nutrients 5(1):267–282

    Article  PubMed  PubMed Central  Google Scholar 

  68. Scolapio JS, Picco MF, Tarrosa VB (2002) Enteral versus parenteral nutrition: the patient’s preference. JPEN J Parenter Enteral Nutr 26(4):248–250

    Article  PubMed  Google Scholar 

  69. Hopkinson J, Corner J (2006) Helping patients with advanced cancer live with concerns about eating: a challenge for palliative care professionals. J Pain Symptom Manag 31(4):293–305

    Article  Google Scholar 

  70. Hopkinson JB, Wright DN, McDonald JW, Corner JL (2006) The prevalence of concerns about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manag 32(4):322–331

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, University of Milan, Via Festa del Perdono 11, 20100, Milan, Italy

    Federico Bozzetti

Authors
  1. Federico Bozzetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Bozzetti.

Ethics declarations

Conflict of interest statement

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bozzetti, F. Nutritional interventions in elderly gastrointestinal cancer patients: the evidence from randomized controlled trials. Support Care Cancer 27, 721–727 (2019). https://doi.org/10.1007/s00520-018-4532-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-018-4532-3

Keywords

Search

Navigation